NCT04359303;Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients;Randomized Clinical Trial to Evaluate Efficacy and Safety of Systemic Indirect Endovenous Ozone Therapy (SIEVOT) as Adjuvant Treatment in COVID19 Non-intubated Patients
